Former Celgene shareholders holding on for a windfall payment from Bristol-Myers Squibb tied to FDA approval of three late-stage drugs saw their hopes dashed as 2020 drew to a close.
Life sciences trade association BioNJ has announced the election of its 2025 Officers and Board Members in concert with BioNJ ...